Evidence map›Paper›PMID 28720732›Full record

ArticlemBio2017

Giulia Orazi, George A O'Toole

Open access · goldAbstract read
In one paragraph

Article in mBio, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 139 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 1 synthesis or guideline pooled it, 225 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. MRSA-dominant colonization and synergistic pathogenicity withJournal of orthopaedic translation · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. UnderstandingMicroorganisms · 2026
    Review
  10. Microbial and host innate immune factors affecting the persistence ofFrontiers in cellular and infection microbiology · 2026
    Review
  11. BioMed research international · 2026
    Review
  12. Journal of bacteriology · 2025
    Article
  13. Review
  14. Article
  15. Article
  16. Detection and Impact ofPathogens (Basel, Switzerland) · 2025
    Article
  17. Calprotectin protectsmSystems · 2025
    Article
  18. Vancomycin Sensitization inACS infectious diseases · 2025
    Article
  19. Review
  20. Ability of Linezolid to CombatAntibiotics (Basel, Switzerland) · 2025
    Article

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Giulia OraziDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
George A O'TooleDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA georgeo@dartmouth.edu.
Dartmouth College · US

Funding

HOST-MICROBE INTERACTIONST32AI007519 · NIAID · DARTMOUTH COLLEGE · PI DEBORAH A HOGAN · 1997 to 2026
$5.9M
cdiGMP regulation of Biofilm FormationR37AI083256 · NIAID · DARTMOUTH COLLEGE · PI O'TOOLE, GEORGE A. · 2014 to 2023
$4.7M
Cellular and Molecular Mechanisms of Lung DiseaseP20GM103413 · NIGMS · DARTMOUTH COLLEGE · PI STANTON, BRUCE A. · 2012 to 2012
$2.1M
NIAID NIH HHS R37 AI083256NIAID NIH HHS T32 AI007519NIGMS NIH HHS P20 GM103413
6 · The paper itself

Abstract

The airways of cystic fibrosis (CF) patients have thick mucus, which fosters chronic, polymicrobial infections.

Indexed as

Microbial InteractionsAnti-Bacterial AgentsBiofilmsBiological FactorsCells, CulturedCystic FibrosisHumansHypoxiaModels, BiologicalPseudomonas aeruginosaStaphylococcus aureusVancomycinAnti-Bacterial AgentsBiological FactorsVancomycinantibiotic tolerancebiofilmscystic fibrosispolymicrobialPseudomonasStaphylococcus aureus

Identifiers

PMID28720732
PMCPMC5516255
OpenAlexW2738713594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.